We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Scientists Find New Drug Target in Breast Cancer

Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments.
News

Titertek Instruments and Berthold Detection Systems GmbH Have Joined Forces

The new company brand name is Titertek-Berthold.
News

Stem Cells from Bone Marrow Save the Day

New research investigates the therapeutic use of human stem cells from bone marrow against acute lung injury and identifies TNF-a-induced protein 6.
News

Benitec Raises AU$8 Million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed

Benitec has received rights issue acceptances for 302,716,126 shares, with the shortfall applications from existing shareholders.
News

Vermillion Announces Notice of Allowance for Peripheral Artery Disease Patent

The patent covers biomarker panels for the diagnosis of Peripheral Artery Disease.
News

PerkinElmer Acquires Labtronics Inc.

The acquisition of Labtronics follows the recent purchase of informatics companies CambridgeSoft and ArtusLabs by PerkinElmer, both announced in March.
News

New Strategy for Drought Tolerance in Crops: Shutting Down the Plant's Growth Inhibition Under Mild Stress

It turns out that under non-lethal stress conditions plants inhibit growth more than absolutely necessary, opening new opportunities for yield improvement.
News

Genetic 'Wiring' of Seeds Revealed

The genetic 'wiring' that helps a seed to decide on the perfect time to germinate has been revealed by scientists for the first time.
News

New Data From Talactoferrin Phase II Trial in Severe Sepsis Presented at American Thoracic Society International Conference

The analysis presented at the conference evaluate the differences in a variety of cytokines and chemokines in patients receiving talactoferrin versus placebo.
News

Cancer Genetics Appoints Elizabeth A. Czerepak as Chief Financial Officer

Ms. Czerepak will lead the finance, clinical billing operations, human resources, and administrative support functions.
Advertisement